



Jørgen R. Jepsen, Francesco d’Amore, 
Ulrik Baandrup, Michael Roost Clausen, 
Elisabeth Gottschalck, and Bent Aasted
Reports of a possible relationship between Aleutian 
mink disease parvovirus (AMDV) and human infection 
are rare. However, 2 mink farmers with vascular disease 
and microangiopathy similar to that in mink with Aleutian 
disease were found to have AMDV-speciﬁ  c antibodies and 
AMDV DNA. These ﬁ  ndings raise the suspicion that AMDV 
may play a role in human disease.
A
utonomous parvoviruses, such as Aleutian mink dis-
ease virus (AMDV), cause a broad spectrum of dis-
eases in animals and man. Acute disease manifests itself 
as a lytic infection of rapidly dividing cells; chronic dis-
ease reﬂ  ects a restricted or abortive infection of speciﬁ  c 
cell types (1). Aleutian disease (AD) is known to produce 
clinical signs in mink and ferrets only (2,3), although other 
mammals have reportedly been antibody positive.
In adult mink, AD is a persistent, slowly progressive 
AMDV infection in which a dysregulated immune system 
and a postinfectious antibody response cause an immune 
complex–mediated vasculitis (2). Perivascular and glomer-
ular immune complexes (2,4,5) can cause membranoprolif-
erative glomerulonephritis (6) and segmental or circumfer-
ential arteritis (4) with mononuclear inﬁ  ltration, ﬁ  brinoid 
necrosis and deposits, and increased intimal cellularity. 
Mononuclear cells may surround the vessel, and connec-
tive tissue proliferation and necrosis in the tunica elastica 
media narrow the lumen (7). In mink kits, AD causes an 
acute cytopathic infection of alveolar cells, which leads to 
respiratory distress and death (8). 
Reports of a possible relationship between AMDV and 
human infection are rare (9). Histopathologic features like 
those in AMDV-infected mink have been described for 2 
patients in the early 1960s (10). Exposed laboratory work-
ers have had persistent anti-AMDV antibodies for up to 18 
months; however, injection of their antibody-positive blood 
into Aleutian mink caused neither lesions nor AMDV-anti-
body production (11). In vitro studies have demonstrated a 
permissive infection (production of infectious progeny) of 
human macrophages with the Utah I strain of AMDV (12). 
We report ﬁ  nding anti-AMDV antibodies and AMDV ge-
nome in tissue from 2 mink farmers with relevant virus ex-
posure and clinical disease similar to that in mink with AD. 
The Study
We examined AMDV antibody from each of the 2 
patients by countercurrent and line electrophoresis (13). 
AMDV DNA was identiﬁ  ed by standard and nested PCR. 
DNA was extracted from lymph nodes (patient 1) and from 
peripheral blood and bone marrow (patient 2) before ampli-
ﬁ  cation with AMDV-speciﬁ  c primers. AMDV DNA was 
identiﬁ  ed by 2 different sets of primers in the standard PCR 
(5–600 bp) and with 2 complete different internal primers 
in the nested PCR (200 bp). PCR products were cloned, 
and some clones were sequenced to conﬁ  rm the presence 
of AMDV DNA. All PCR reactions were done with ap-
propriate controls.
Patient 1 was a mink farmer who had been exposed 
to AMDV-infected mink for 10 years. When he was 22 
years of age, toe ulceration and claudication developed. 
Arteriography showed bilateral occlusions of several 
lower limb arteries and associated development of a col-
lateral network of vessels. At the age of 25, he underwent 
embolectomy, and the removed tissue showed vessel wall 
inﬂ  ammation with a granulomatous appearance but no 
necrotizing lesions or epitheloid or eosinophilic inﬁ  ltra-
tion. Over the next 10 years, despite surgical attempts to 
revascularize and treatment with anticoagulant drugs, his 
condition deteriorated: his renal, mesenteric, and axillary 
arteries became stenosed, and his right leg was amputated. 
Antibodies to AMDV were found in his serum at the end 
of these 10 years and at 2 subsequent measurements after 
1 additional year. An abdominal aortic biopsy showed ad-
ventitial lymphoplasmacytic cell inﬁ  ltration and minimal 
atherosclerosis (Figure 1). A lymph node biopsy sample 
showed modest reactive changes and T-zone hyperpla-
sia, and AMDV DNA was identiﬁ  ed in the sample. At 
35 years of age, the patient had a positive serologic result 
for anti-AMDV antibodies and severe claudication. Sub-
sequent testing 1 and 2 years later showed negative results 
for AMDV antibodies and AMDV genome. The patient 
died in 1999, at 40 years of age, at which time his clinical 
condition resembled that of bilateral pneumonia. No spe-
ciﬁ  c infectious agent was identiﬁ  ed. Postmortem exami-
nation showed periarterial collagen deposits, adventitial 
focal mononuclear accumulations, neutrophil inﬁ  ltration 
in the media, ﬁ  brosis-related hyperplasia, lipid deposi-
tion and calciﬁ  cations of the intima, and microabscesses 
within intraluminal thrombotic material.
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Patient 2 was also a mink farmer. He had been exposed 
to AMDV since the age of 20. At 54 years of age, 2 years 
after an extensive outbreak of AMDV among his mink, he 
was hospitalized for chronic glomerulonephritis. A renal 
biopsy sample showed endocapillary and mesangial prolif-
erative glomerulonephritis with abundant focal semilunes 
(Figure 2, panel A). Immunoﬂ   uorescence showed anti-
immunoglobulin M and anti-C3 antibodies localized to the 
renal capillaries. Electron microscopy showed organized 
ﬁ  brillar deposits of stacked microtubules of ≈20 nm (Fig-
ure 2, panel B), consistent with ﬁ  brillary glomerulonephri-
tis (14), an idiopathic condition characterized by polyclonal 
immune deposits with restricted gamma isotypes. No se-
roimmunologic information was available for the patient at 
this time. Immunosuppression improved his renal function, 
and he remained stable while receiving continuous immu-
nosuppressive medication. 
Eight years later, patient 2 was readmitted to the hospi-
tal for diarrhea, vomiting, pyrexia, asthenia, and confusion. 
Cerebrospinal ﬂ  uid contained high levels of protein and 
pleocytosis, but no speciﬁ  c infectious agent could be iso-
lated from the cerebrospinal ﬂ  uid or blood. Magnetic reso-
nance imaging showed an increased meningeal signal over 
both cerebral hemispheres. Subsequent investigations re-
peatedly demonstrated anti-AMDV antibodies and AMDV 
DNA in peripheral blood and bone marrow. Serum was still 
positive for AMDV antibodies 2 years later. Despite treat-
ment with antimicrobial drugs, the patient further deterio-
rated and died in 2004, at age 63, after an additional year 
of hospitalization. At postmortem examination, the kidneys 
were reduced in size with evidence of cortical attenuation. 
Increased mesangial hypercellularity was observed. An ad-
enocarcinoma of the right lung had metastasized to the su-
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 12, December 2009  2041 
Figure 1. Histopathologic appearance of abdominal aortic biopsy 
sample from 35-year-old mink farmer in Denmark who had been 
exposed to Aleutian mink disease parvovirus−infected mink for 10 
years (patient 1). A) Perivascular, adventitial lymphoplasmacytoid 
inﬁ   ltration. Original magniﬁ   cation ×4. B) Minimal atherosclerotic 
changes. Original magniﬁ  cation ×20.
Figure 2. Histopathologic appearance of renal biopsy sample 
from 54-year-old mink farmer in Denmark who had been exposed 
to Aleutian mink disease parvovirus−infected mink for 34 years 
(patient 2). A) Glomeruli with hypercellularity and crescents. 
Original magniﬁ   cation ×20. B) Electron microscopy showing 
distinct extracellular deposits of coarse 20-nm ﬁ  brils (microtubular 
structures) characterized as immunotactoid glomerulopathy. 
Original magniﬁ  cation ×100,000.prarenal glands, liver, and mesenterium. Coronary arteries 
and the aorta were moderately atherosclerotic.
Conclusions
The clinical history, histopathologic features, and mo-
lecular ﬁ  ndings for the 2 mink farmers exposed to AMDV 
were similar to those described for AD in mink. The com-
bination of clinical and laboratory ﬁ  ndings is unique for 
these patients compared with previous reports. These 2 
patients had micro- and macroangiopathic lesions and 
prolonged persistence of serum antibodies to AMDV and 
AMDV DNA.
On the basis of its early onset, dissemination, and se-
verity, the slight atherosclerosis found in some histopato-
logic specimens from patient 1 represent a consequence of 
the pre-existing arteritis rather than a primary condition. 
Buerger disease is unlikely on the basis of cytopathologic 
and histopathologic ﬁ  ndings, and other vasculitic disorders 
were excluded on the basis of serologic ﬁ  ndings. The ar-
teritis was similar to the autoimmune vascular lesions ac-
companying AD in mink with adventitial lymphocytic in-
ﬁ  ltration (4). The histopathologic ﬁ  ndings for patient 2, in 
whom the autoimmune glomerulonephritis was diagnosed 
8 years before the ﬁ  rst measurement of anti-AMDV anti-
bodies, resembled the immune complex–mediated glom-
erulonephritis in mink with AD (6).
For patient 1, anti-AMDV antibodies persisted 4 years 
from his last exposure to mink, exceeding the longest re-
ported duration of positive AMDV response in a human 
in the absence of virus exposure (11). Similarly, patient 2 
had a long-lasting antibody response, although under po-
tentially persisting exposure. The persistence of anti-AM-
DV antibodies in patient 2 may reﬂ  ect host-related factors 
in the modulation of immune response to chronic antigen 
stimulation. In mink, host-related factors inﬂ  uence their 
susceptibility to AMDV infection and correlate with clini-
cal manifestations from an asymptomatic condition to overt 
disease. One may speculate whether the overrepresentation 
of malignant lymphoma in mink farmers could reﬂ  ect a part 
of a disease spectrum paralleling monoclonal plasma cell 
proliferation in mink (15).
That AMDV DNA was found only in the ﬁ  rst biopsy 
sample from patient 1 may weaken the hypothesis of vi-
rus replication. However, it may reﬂ  ect technical difﬁ  cul-
ties with DNA ampliﬁ  cation after parafﬁ  n embedding of 
the specimen or a possible later clearance of the virus from 
infected tissues. Regardless, we have described our clinico-
pathologic and molecular ﬁ  ndings with the goal of raising 
awareness about the possible role of AMDV replication in 
human disease. 
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